Weijie Ma

2.1k total citations · 1 hit paper
57 papers, 1.3k citations indexed

About

Weijie Ma is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Weijie Ma has authored 57 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 21 papers in Cancer Research and 16 papers in Oncology. Recurrent topics in Weijie Ma's work include RNA modifications and cancer (17 papers), Cancer-related molecular mechanisms research (16 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Weijie Ma is often cited by papers focused on RNA modifications and cancer (17 papers), Cancer-related molecular mechanisms research (16 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Weijie Ma collaborates with scholars based in China, United States and France. Weijie Ma's co-authors include Yufeng Yuan, Hao Zhang, Peng Xia, Tian Lan, Yinghong Wang, Xiang Jiang, Xi Chen, Xi Chen, Anusha Shirwaikar Thomas and Ye Yao and has published in prestigious journals such as New England Journal of Medicine, Advanced Materials and Journal of Clinical Oncology.

In The Last Decade

Weijie Ma

52 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

METTL5 stabilizes c‐Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression

2023 99 citations Peng Xia, Hao Zhang et al. Cancer Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Weijie Ma China	20	919	634	226	152	123	57	1.3k
Zhibin Liao China	21	794 0.9×	468 0.7×	181 0.8×	100 0.7×	79 0.6×	47	1.0k
Hanchu Xiong China	17	746 0.8×	589 0.9×	148 0.7×	136 0.9×	97 0.8×	35	1.1k
Wenting Pan China	21	840 0.9×	634 1.0×	163 0.7×	116 0.8×	87 0.7×	65	1.2k
Zhixiang Hu China	17	994 1.1×	639 1.0×	114 0.5×	84 0.6×	99 0.8×	42	1.3k
Tianqiang Song China	18	749 0.8×	570 0.9×	145 0.6×	89 0.6×	89 0.7×	31	1.1k
Long Wu China	17	771 0.8×	634 1.0×	147 0.7×	103 0.7×	83 0.7×	54	1.1k
Li Zhuang China	16	804 0.9×	644 1.0×	90 0.4×	244 1.6×	109 0.9×	36	1.1k
Bisha Ding China	24	1.2k 1.3×	1.1k 1.7×	125 0.6×	207 1.4×	53 0.4×	34	1.6k
Lincan Duan China	15	1.8k 2.0×	983 1.6×	299 1.3×	241 1.6×	76 0.6×	37	2.1k
Shenmeng Gao China	21	894 1.0×	572 0.9×	154 0.7×	68 0.4×	117 1.0×	49	1.2k

Countries citing papers authored by Weijie Ma

Since Specialization

Citations

This map shows the geographic impact of Weijie Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijie Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijie Ma more than expected).

Fields of papers citing papers by Weijie Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weijie Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijie Ma. The network helps show where Weijie Ma may publish in the future.

Co-authorship network of co-authors of Weijie Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Weijie Ma. A scholar is included among the top collaborators of Weijie Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weijie Ma. Weijie Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Xiaoling, Yiran Chen, Wenzhi He, et al.. (2025). UBE2Q2 promotes tumor progression and glycolysis of hepatocellular carcinoma through NF-κB/HIF1α signal pathway. Cellular Oncology. 48(3). 637–654. 2 indexed citations

Ma, Weijie, et al.. (2025). Edge-induced selective etching of bilayer MoS ₂ kirigami structures via a space-confined method. Nanoscale Horizons. 10(5). 957–965. 4 indexed citations

Liu, Yifan, Wenkai Liu, Wei Xu, et al.. (2025). A Novel Quasi-Zero Stiffness Vibration Isolator Via Biaxial Slider-Connector-Spring Structure. Journal of Vibration Engineering & Technologies. 13(6).

Zhang, Qing, Minghui Li, Weijie Ma, et al.. (2024). Space-Confined Vertical Growth of Large-Size Organic Semiconductor Single Crystals. ACS Applied Materials & Interfaces. 16(49). 68120–68130. 2 indexed citations

Zhang, Qing, Linfeng Li, Weijie Ma, et al.. (2024). Surface‐Assisted Passivation Growth of 2D Ultrathin β‐Bi₂O₃ Crystals for High‐Performance Polarization‐Sensitive Photodetectors. Advanced Materials. 37(3). e2410163–e2410163. 12 indexed citations

Xia, Peng, Hao Zhang, Haofeng Lu, et al.. (2023). METTL5 stabilizes c‐Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression. Cancer Communications. 43(3). 338–364. 99 indexed citations breakdown →

Li, Jinghua, Bin Liu, Wei Jing, et al.. (2023). Cavin1 activates the Wnt/β-catenin pathway to influence the proliferation and migration of hepatocellular carcinoma. Annals of Hepatology. 29(1). 101160–101160. 2 indexed citations

Guo, Yonghua, Ye Yao, Jinghua Li, et al.. (2022). Prognostic value of CSN5 in patients with digestive system cancers: a systematic review and meta-analysis. BMC Cancer. 22(1). 812–812.

Chen, Xi, Weijie Ma, Ye Yao, et al.. (2021). Serum deprivation-response protein induces apoptosis in hepatocellular carcinoma through ASK1-JNK/p38 MAPK pathways. Cell Death and Disease. 12(5). 425–425. 32 indexed citations

10.

Xia, Peng, Hao Zhang, Kequan Xu, et al.. (2021). MYC-targeted WDR4 promotes proliferation, metastasis, and sorafenib resistance by inducing CCNB1 translation in hepatocellular carcinoma. Cell Death and Disease. 12(7). 691–691. 171 indexed citations

11.

Zhang, Hao, Peng Xia, Jie Liu, et al.. (2021). ATIC inhibits autophagy in hepatocellular cancer through the AKT/FOXO3 pathway and serves as a prognostic signature for modeling patient survival. International Journal of Biological Sciences. 17(15). 4442–4458. 45 indexed citations

12.

Khurana, Shruti, Weijie Ma, Zhi‐Dong Jiang, et al.. (2021). Safety and efficacy of fecal microbiota transplantation to treat and prevent recurrent Clostridioides difficile in cancer patients. Journal of Cancer. 12(21). 6498–6506. 9 indexed citations

13.

Ma, Weijie, Ye Yao, Gang Xu, et al.. (2021). Identification of a seven-long non-coding RNA signature associated with Jab1/CSN5 in predicting hepatocellular carcinoma. Cell Death Discovery. 7(1). 178–178. 7 indexed citations

14.

Zhang, Hao, Peng Xia, Weijie Ma, & Yufeng Yuan. (2021). Development and Validation of an RNA Binding Protein-associated Prognostic Model for Hepatocellular Carcinoma. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 4 indexed citations

15.

Jiang, Xiang, Yingyi Liu, Ganggang Wang, et al.. (2020). Up-regulation of CLIC1 activates MYC signaling and forms a positive feedback regulatory loop with MYC in Hepatocellular carcinoma.. PubMed Central. 10(8). 2355–2370. 16 indexed citations

16.

Jiang, Xiang, Ganggang Wang, Yingyi Liu, et al.. (2020). A novel long non-coding RNA RP11-286H15.1 represses hepatocellular carcinoma progression by promoting ubiquitination of PABPC4. Cancer Letters. 499. 109–121. 27 indexed citations

17.

Tang, Tenglong, Hamzah Abu‐Sbeih, Weijie Ma, et al.. (2020). Gastrointestinal Injury Related to Antiangiogenesis Cancer Therapy. Clinical Colorectal Cancer. 19(3). e117–e123. 6 indexed citations

18.

Xie, Weiling, Weijie Ma, Pan Liu, & Fuling Zhou. (2019). Overview of thioredoxin system and targeted therapies for acute leukemia. Mitochondrion. 47. 38–46. 29 indexed citations

19.

Wu, Long, Lei Chang, Haitao Wang, et al.. (2017). Clinical significance of C/D box small nucleolar RNA U76 as an oncogene and a prognostic biomarker in hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology. 42(1). 82–91. 37 indexed citations

20.

Chang, Lei, Cuicui Li, Tao Guo, et al.. (2016). The human RNA surveillance factor UPF1 regulates tumorigenesis by targeting Smad7 in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 35(1). 8–8. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact